BLINDDATE

Welcome to the Brand page for “BLINDDATE”, which is offered here for Pharmaceutical preparations for the treatment of cancer, viral infections, autoimmune diseases, and tumorous diseases; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugs, pharmaceutical preparations for the treatment of cancer, viral infections, autoimmune diseases, tumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discovery, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic reagents used in connection with protein engineering and biological drug development;blind date;scientific and technological services, pharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discovery, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services;.

Its status is currently believed to be active. Its class is unavailable. “BLINDDATE” is believed to be currently owned by “Immunocore Limited”.